Richard Newitter
Stock Analyst at Truist Securities
(3.97)
# 631
Out of 5,180 analysts
457
Total ratings
49.4%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Buy | $27 → $35 | $19.17 | +82.58% | 6 | Mar 19, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $95 → $92 | $62.75 | +46.61% | 22 | Mar 18, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $47 → $30 | $25.01 | +19.95% | 17 | Mar 2, 2026 | |
| KIDS OrthoPediatrics | Maintains: Hold | $19 → $20 | $15.87 | +26.02% | 11 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $82 → $89 | $75.85 | +17.34% | 23 | Mar 2, 2026 | |
| SIBN SI-BONE | Reiterates: Buy | $23 → $24 | $12.63 | +90.02% | 2 | Feb 24, 2026 | |
| IRTC iRhythm Holdings | Reiterates: Buy | $215 → $200 | $118.02 | +69.46% | 20 | Feb 23, 2026 | |
| ITGR Integer Holdings | Maintains: Buy | $95 → $97 | $88.00 | +10.23% | 13 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $390 → $360 | $209.84 | +71.56% | 5 | Feb 19, 2026 | |
| DXCM DexCom | Reiterates: Buy | $82 → $80 | $62.80 | +27.39% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $96 → $70 | $51.58 | +35.71% | 31 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $92 → $89 | $80.08 | +11.14% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $25 | $10.02 | +149.50% | 6 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $328.37 | +13.90% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $32.17 | +39.88% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.34 | +123.88% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $400 → $392 | $328.59 | +19.30% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $86.65 | +23.49% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $460.99 | +41.00% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $107.66 | +34.68% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $86.16 | +21.87% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $9.05 | +120.99% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $9.42 | +59.24% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $119.61 | +14.54% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $90.42 | +24.97% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $6.16 | +224.68% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $75.35 | +8.83% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $157.23 | +59.00% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.37 | +997.05% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $171.43 | +349.16% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.59 | +12.45% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $5.96 | +235.57% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $33.13 | -18.50% | 5 | Feb 23, 2021 |
Tandem Diabetes Care
Mar 19, 2026
Upgrades: Buy
Price Target: $27 → $35
Current: $19.17
Upside: +82.58%
Boston Scientific
Mar 18, 2026
Maintains: Buy
Price Target: $95 → $92
Current: $62.75
Upside: +46.61%
PROCEPT BioRobotics
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $25.01
Upside: +19.95%
OrthoPediatrics
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $15.87
Upside: +26.02%
Lantheus Holdings
Mar 2, 2026
Maintains: Buy
Price Target: $82 → $89
Current: $75.85
Upside: +17.34%
SI-BONE
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $12.63
Upside: +90.02%
iRhythm Holdings
Feb 23, 2026
Reiterates: Buy
Price Target: $215 → $200
Current: $118.02
Upside: +69.46%
Integer Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $88.00
Upside: +10.23%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $390 → $360
Current: $209.84
Upside: +71.56%
DexCom
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $62.80
Upside: +27.39%
Feb 12, 2026
Maintains: Hold
Price Target: $96 → $70
Current: $51.58
Upside: +35.71%
Feb 11, 2026
Maintains: Hold
Price Target: $92 → $89
Current: $80.08
Upside: +11.14%
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $10.02
Upside: +149.50%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $328.37
Upside: +13.90%
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $32.17
Upside: +39.88%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.34
Upside: +123.88%
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $328.59
Upside: +19.30%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $86.65
Upside: +23.49%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $460.99
Upside: +41.00%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $107.66
Upside: +34.68%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $86.16
Upside: +21.87%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $9.05
Upside: +120.99%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $9.42
Upside: +59.24%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $119.61
Upside: +14.54%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $90.42
Upside: +24.97%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $6.16
Upside: +224.68%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $75.35
Upside: +8.83%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $157.23
Upside: +59.00%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.37
Upside: +997.05%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $171.43
Upside: +349.16%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.59
Upside: +12.45%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $5.96
Upside: +235.57%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $33.13
Upside: -18.50%